The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.
Stumpfova
Magda
M
Departments of Pathology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Ratner
Desirée
D
Desciak
Edward B
EB
Eliezri
Yehuda D
YD
Owens
David M
DM